newsfilter
← Latest News
PR Newswire·

VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating...